Vicus Capital Bristol Myers Squibb CO Transaction History

Vicus Capital

$1.12 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$40.25 - $52.99 $37,996 - $50,022	944 Added 24.37%	4,817 $200,000
Q1 2024 Apr 17, 2024	BUY	$47.98 - $54.4 $185,826 - $210,691	3,873 New	3,873 $210,000
Q3 2023 Oct 23, 2023	BUY	$57.89 - $64.73 $10,362 - $11,586	179 Added 3.85%	4,824 $279,000
Q2 2023 Aug 17, 2023	BUY	$63.71 - $70.74 $56,383 - $62,604	885 Added 23.54%	4,645 $297,000
Q1 2023 May 02, 2023	BUY	$65.71 - $74.53 $854 - $968	13 Added 0.35%	3,760 $260,000
Q4 2022 Feb 15, 2023	SELL	$68.48 - $81.09 $5,204 - $6,162	-76 Reduced 1.99%	3,747 $269,000
Q3 2022 Nov 08, 2022	SELL	$0.13 - $76.84 $99 - $59,089	-769 Reduced 16.75%	3,823 $272,000
Q2 2022 Aug 10, 2022	SELL	$72.62 - $79.98 $170,148 - $187,393	-2,343 Reduced 33.79%	4,592 $354,000
Q1 2022 May 11, 2022	SELL	$61.48 - $73.72 $13,156 - $15,776	-214 Reduced 2.99%	6,935 $506,000
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $383,400 - $446,955	7,149 New	7,149 $464,000
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $480,173 - $522,909	-7,756 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$59.34 - $66.74 $8,129 - $9,143	137 Added 1.8%	7,756 $490,000
Q4 2020 Feb 01, 2021	SELL	$57.74 - $65.43 $85,166 - $96,509	-1,475 Reduced 16.22%	7,619 $473,000
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $57,889 - $64,149	1,008 Added 12.47%	9,094 $548,000
Q2 2020 Aug 03, 2020	BUY	$54.82 - $64.09 $2,137 - $2,499	39 Added 0.48%	8,086 $475,000
Q1 2020 May 07, 2020	BUY	$46.4 - $67.43 $46 - $67	1 Added 0.01%	8,047 $449,000
Q4 2019 Feb 04, 2020	BUY	$49.21 - $64.19 $86,019 - $112,204	1,748 Added 27.75%	8,046 $516,000
Q3 2019 Nov 18, 2019	BUY	$42.77 - $50.71 $269,365 - $319,371	6,298 New	6,298 $319,000
Q4 2017 Jan 25, 2018	SELL	$59.94 - $65.35 $301,857 - $329,102	-5,036 Closed	0 $0
Q3 2017 Oct 27, 2017	BUY	$55.23 - $63.74 $278,138 - $320,994	5,036	5,036 $321,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.34 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.47 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.59 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.59 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vicus Capital, based on Form 13F filings with the SEC.

News

Stay updated on Vicus Capital with notifications on news.

Account